According to the recent research, there are over 80% of people would be motivated to exercise if incentivized by crypto...


Recent Study Reveals That Crypto Motivates People to Exercise

On Friday, Prime Minister Ranil Wickremesinghe warned of a food shortage as the island nation battles a devastating economic...


Thousands queue for petrol, gas in Sri Lanka amid warnings of food shortages

ASML, a semiconductor industry and stock market giant, might have to think smaller. Or maybe bigger. Currently, it is building machines...


Computer chip giant ASML places big bets on a tiny future

Finance ministers and central bank governors of the United States, Japan, Canada, Britain, Germany, France and Italy - the G7, agreed on...


Money for Ukraine Priority in G7 Agenda; Inflation, Food a Concern

An auto safety agency in the U.S. said on Wednesday that it has opened an investigation into a fatal crash involving a Tesla...

Stock Markets

U.S. Agency opens investigation involving Tesla due to 14 Crash Deaths


9 Sept 2021

FDA Declines Emergency use of Humanigen's COVID-19 Drug

FDA Declines Emergency use of Humanigen's COVID-19 Drug

The Index Today

The U.S. Food and Drug Administration announced that they declined Humanigen Inc's request for emergency use authorization (EUA) of the lenzilumab drug to treat newly hospitalized COVID-19 patients.
The company said in a statement that it was unable to conclude that the known and potential benefits of lenzilumab surpass the known and potential risks of its use as a treatment for COVID-19.
Humanigen Inc expects to have an ongoing study to provide additional safety and data of effectiveness to support its request of EUA.
Humanigen also started the process of UK authorization for the lenzilumab drug last June through a rolling review submission.
©Photo: wusa9